Saturday, August 8, 2020

Relief Therapeutics sees 60-70% chance of COVID-19 drug approval

Relief Therapeutics sees 60-70% chance of COVID-19 drug approval The Swiss group owns the rights to the drug in the United States and Europe.

from Moneycontrol Business News https://ift.tt/2PzCUk3

No comments:

Post a Comment

Bajaj Auto shares fall 2% as firm, subsidiary fall prey to ransomware attack

Bajaj Auto shares dipped 2% following a ransomware attack on its systems and subsidiary, Bajaj Auto Technology Ltd, on June 23, 2026. The co...